SCHEMBL21378367

SCHEMBL21378367

CC(F)[C@H]1COC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21378368 1.00
SCHEMBL22158785 1.00
SCHEMBL19700730 1.00
SCHEMBL16045961 1.00
SCHEMBL19692708 1.00
SCHEMBL16055022 1.00
SCHEMBL22158786 1.00
SCHEMBL16046312 0.84
SCHEMBL16046314 0.84
SCHEMBL18360702 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112262145-B 2-aminopyrimidine derivative and preparation method and application thereof 上海奕拓医药科技有限责任公司 2023-08-01 CN disclosed
CN-109311863-B Mutant IDH1 inhibitors 伊莱利利公司 2021-10-29 CN disclosed
CN-112262145-A 2-aminopyrimidine derivatives, preparation method and application thereof 上海奕拓医药科技有限责任公司 2021-01-22 CN disclosed
EP-3464281-B1 MUTANT IDH1 INHIBITORS LILLY CO ELI (US) 2020-07-08 EP disclosed
US-10696665-B2 Mutant IDH1 inhibitors ELI LILLY AND COMPANY (US) 2020-06-30 US disclosed
US-20190292175-A1 MUTANT IDH1 INHIBITORS ELI LILLY AND COMPANY 2019-09-26 US disclosed